If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKier Regulatory News (KIE)

Share Price Information for Kier (KIE)

Share Price is delayed by 15 minutes
Get Live Data
226.20    -2.40 (-1.05%)
Bid:
226.00
Ask:
226.40
Spread: 0.40 (0.177%)
Market Cap: £990.41m
KIE Live PriceLast checked at - London Stock Exchange

Intraday Kier Share Chart

Board Change

22 May 2020 07:00

RNS Number : 6861N
Kier Group PLC
22 May 2020
 

Kier Group plc

 

Board Change

 

Kier Group plc ("the Company") announces that Kirsty Bashforth has informed the board of directors ("the Board") that she will not seek re-election as a non-executive director of the Company at its Annual General Meeting in November 2020 and will, therefore, stand down from the Board with effect from the conclusion of that meeting.

 

Kirsty joined the Board in September 2014 and has served as a member of each of its committees. Kirsty has been the Chair of the Board's Safety, Health and Environment Committee ("the SHE Committee") since November 2018.

 

Matthew Lester, Chairman of the Board, said: "I look forward to continuing to work with Kirsty over the next few months and, in the meantime, would like to thank Kirsty for her service in almost six years on the Board. In particular, as the Chair of the SHE Committee, Kirsty has overseen the Company's continuous focus on its key priorities of safety, health and the environment."

 

This announcement is made in accordance with Listing Rule 9.6.11R.

 

- ENDS -

 

For further information, please contact:

Richard Mountain/Nick Hasell - FTI Consulting

Kier press office

 

+44 (0)203 727 1340

+44 (0) 1767 355 096

 

 

Cautionary statement

This announcement does not constitute an offer of securities by Kier Group plc (the "Company"). Nothing in this announcement is intended to be, or intended to be construed as, a profit forecast or a guide as to the performance, financial or otherwise, of the Company or any of its subsidiaries (together, the "Group") whether in the current or any future financial year. This announcement may include statements that are, or may be deemed to be, ''forward-looking statements''. By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future and may be beyond the Company's or the Group's ability to control or predict. Forward-looking statements are not guarantees of future performance. You are advised to read the section headed ''Principal risks and uncertainties'' in the Company's Annual Report and Accounts for the year ended 30 June 2019 and the Company's results announcement for the six months ended 31 December 2019 for further information about the factors that could affect the Company's or the Group's future performance and the industry in which it operates. Other than in accordance with its legal or regulatory obligations, the Company does not accept any obligation to update or revise publicly any forward-looking statement, whether as a result of new information, future events or otherwise.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOABIGDULUDDGGB
Date   Source Headline
12th Mar 20269:33 amRNSTransaction in Own Shares
11th Mar 20263:53 pmRNSDirector/PDMR Shareholding
11th Mar 20263:53 pmRNSDirector/PDMR Shareholding
11th Mar 20269:27 amRNSTransaction in Own Shares
11th Mar 20269:27 amRNSTransaction in Own Shares
10th Mar 20269:07 amRNSTransaction in Own Shares
10th Mar 20269:07 amRNSTransaction in Own Shares
9th Mar 20269:36 amRNSTransaction in Own Shares
6th Mar 20269:22 amRNSTransaction in Own Shares
5th Mar 20269:34 amRNSTransaction in Own Shares
3rd Mar 20267:07 amRNSResults for the period ended 31 December 2025
3rd Mar 20267:05 amRNSDirectorate change
3rd Mar 20267:02 amRNSCommencement of £25m share buyback programme
23rd Feb 20265:15 pmRNSHolding(s) in Company
23rd Feb 202612:15 pmRNSHolding(s) in Company
20th Feb 202611:10 amRNSHolding(s) in Company
20th Feb 202611:09 amRNSDirector/PDMR Shareholding
17th Feb 202611:00 amRNSHolding(s) in Company
13th Feb 20265:24 pmRNSHolding(s) in Company
10th Feb 20263:45 pmRNSHolding(s) in Company
5th Feb 20265:30 pmRNSHolding(s) in Company
3rd Feb 20264:30 pmRNSHolding(s) in Company
2nd Feb 20263:40 pmRNSHolding(s) in Company
2nd Feb 20263:30 pmRNSTotal Voting Rights
21st Jan 20265:30 pmRNSHolding(s) in Company
21st Jan 20263:00 pmRNSHolding(s) in Company
20th Jan 20263:20 pmRNSDirector/PDMR Shareholding
20th Jan 20267:00 amRNSTrading Update
19th Jan 20263:00 pmRNSHolding(s) in Company
16th Jan 20265:00 pmRNSHolding(s) in Company
15th Jan 20264:30 pmRNSHolding(s) in Company
14th Jan 20265:15 pmRNSHolding(s) in Company
13th Jan 20263:00 pmRNSHolding(s) in Company
12th Jan 20265:00 pmRNSHolding(s) in Company
8th Jan 20264:30 pmRNSHolding(s) in Company
7th Jan 20265:00 pmRNSHolding(s) in Company
5th Jan 20265:00 pmRNSHolding(s) in Company
5th Jan 20263:00 pmRNSHolding(s) in Company
5th Jan 20263:00 pmRNSHolding(s) in Company
2nd Jan 202611:05 amRNSBlock listing Interim Review
2nd Jan 202611:00 amRNSTotal Voting Rights
22nd Dec 20254:37 pmRNSDirector/PDMR Shareholding
22nd Dec 20254:37 pmRNSDirector/PDMR Shareholding
18th Dec 202510:52 amRNSHolding(s) in Company
17th Dec 20258:00 amRNSCompletion of £20m share buyback programme
17th Dec 20257:00 amRNSTransaction in Own Shares
16th Dec 20255:07 pmRNSHolding(s) in Company
16th Dec 20255:06 pmRNSDirector/PDMR Shareholding
16th Dec 20257:00 amRNSTransaction in Own Shares
15th Dec 20255:04 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.